Pulse Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Pulse Biosciences

30/03/2023 22:44

* Pulse Biosciences Inc  PLSE.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended in December.
The lone analyst forecast for the quarter was for a loss of 24
cents per share.
    * Revenue fell 99% to $9.00 thousand from a year ago;
analysts
expected zero. 
    * Pulse Biosciences Inc's reported EPS for the quarter was a
loss
of 25 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulse Biosciences Inc shares had fallen by 9.4% this
quarter.
    * The company reported a quarterly loss of $9.2 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 30 at 09:44 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.24          -0.25          Missed
 Sep. 30 2022      -0.45          -0.49          Missed
 Jun. 30 2022      -0.40          -0.44          Missed
 Mar. 31 2022      -0.52          -0.58          Missed